| Application no. and date | 10165256.8 (espacenet) (Federated) (European Patent Register), 20021022 | | Patent/reg. no. and date | DK/EP 2219031, 20130424 | | Publication date | 20100818 | | Priority no. and date | US 336394 P, 20011022 | | EP pub. no. and date |
EP 2219031 20100818 | | Effective date | | | Applicant/owner | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS
SYSTEM, 201 West 7th Street
Austin, Texas 78701, US,
Amgen, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US,
The Government of the United States of America,
represented by The Secretary, Department of Health
and Human Services, National Institutes of Health
Office of Technology Transfer
Suite 325, 6011 Executive Boulevard
Rockville, MD 20852, US | | Applicant ref. no. | 157171 | | Inventor | Garg, A.,
5323 Harry Hines Boulevard
Dallas, TX 57390, US,
Depaoli, Alex M, Amgen, Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320, US,
Oral, Elif Arioglu, c/o Amylin Pharmaceuticals, Inc.,
9360 Towne Center Drive
San Diego,
CA 92121, US,
Taylor, Simeon I, c/o Amylin Pharmaceuticals, Inc.
9360 Towne Center Drive
San Diego,
CA 92121, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/18 (2006.01) , A61K 38/19 (2006.01) , A61P 3/06 (2006.01) , A61P 3/10 (2006.01) , G01N 33/53 (2006.01) | | Title | Anvendelse af leptin til behandling af human lipoatrofi og fremgangsmåde til bestemmelse af prædisposition for behandlinngen | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
